Clinical Trial Update: Double Blind Randomized Placebo Controlled Trial of FOSTRAP Chewing Gum in Patients With CKD and Hyperphosphatemia [Phase 1]

View source ↗

Summary

A Phase 1 double-blind, randomized, placebo-controlled trial evaluating FOSTRAP chewing gum in patients with chronic kidney disease and hyperphosphatemia has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperphosphatemia

Drugs mentioned

• FOSTRAP Chewing Gum

Snippet

Sponsor: Denver Nephrologists, P.C. | Conditions: Hyperphosphatemia, Chronic Kidney Disease | Phase 1 | Status: COMPLETED